Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Brian M Frier

11PUBLICATIONS
22CO-AUTHORS
Nutrigenomics and personalised nutritionMajor global burdens of diseaseComputational methods in fluid flow, heat and mass transfer (incl. computational fluid dynamics)Epigenetics (incl. genome methylation and epigenomics)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Nov 03, 2025
Importance of targeting post-prandial hyperglycaemia to achieve HbA1c goals in insulin glargine-treated subphenotypes of type 2 diabetes.

Wolfgang Landgraf, David R Owens, Brian M Frier

|Nov 20, 2024
Severe hypoglycaemia and diabetic ketoacidosis in adults presenting to a hospital emergency department: Adverse prognostic markers for survival in type 2 diabetes and the role of SGLT2 inhibitors.

Soon H Song, Brian M Frier

|Nov 04, 2024
Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational real-world study.

Gillian L Garden, Ka Siu Fan, Megan Paterson

|Jun 15, 2024
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis.

Wolfgang Landgraf, David R Owens, Brian M Frier

|Oct 20, 2023
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial.

Wolfgang Landgraf, David R Owens, Brian M Frier

|Dec 11, 2019
Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon.

Vivian T Thieu, Beth D Mitchell, Oralee J Varnado

Pageof 2

Frequent Collaborators

6 joint publications

Geremia B Bolli

6 joint publications

David R Owens

5 joint publications

Wolfgang Landgraf

2 joint publications

Simon R Heller

1 joint publications

Luigi Meneghini

1 joint publications

Alison J Dunkley

1 joint publications

Laura J Gray

1 joint publications

Melanie J Davies

1 joint publications

Kamlesh Khunti

1 joint publications

Stewart B Harris

Frequent Collaborators

6 joint publications

Geremia B Bolli

6 joint publications

David R Owens

5 joint publications

Wolfgang Landgraf

2 joint publications

Simon R Heller

Top Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on : Jun 11, 2012

19.3K
See more related videos

Top Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on : Jun 11, 2012

19.3K
See more related videos